TRESLEEN Side Effects

6344220-8 | Hyponatraemia
on Aug 24, 2009 Female patient from AUSTRIA , 80 years of age, was treated with Tresleen (View Usage). Patient experienced the following unwanted or unexpected effects: hyponatraemia. Tresleen dosage: . During the same period patient was treated with FUROHEXAL (40 Mg, 2x/day) (View Furohexal Review and Furohexal Label ), ASPIRIN (100 Mg, Unk) (View Aspirin Review and Aspirin Label ), CLYSMOL (View Clysmol Review and Clysmol Label ), BISOPROLOL FUMARATE (1.25 Mg, 1x/day) (View Bisoprolol Fumarate Review and Bisoprolol Fumarate Label ), DANCOR (10 Mg, 2x/day) (View Dancor Review and Dancor Label ), ENAC (2.5 Mg, 2x/day) (View Enac Review and Enac Label ), EUTHYROX (75 Ug, Unk) (View Euthyrox Review and Euthyrox Label ), HALCION (0.25 Mg, Unk) (View Halcion Review and Halcion Label ). Patient was hospitalized.

5675983-2 | No Adverse Event
Patient was taking Tresleen (View Usage). Patient had the following side effects: no adverse event on Feb 01, 2008 from AUSTRIA Additional patient health information: Female patient , 71 years of age, was diagnosed with dementia alzheimer's type and. Tresleen dosage: . During the same period patient was treated with HALDOL (Daily Dose:1.5mg) (View Haldol Review and Haldol Label ), ARICEPT (View Aricept Review and Aricept Label ), SEROQUEL (Daily Dose:200meq) (View Seroquel Review and Seroquel Label ), MIRTAZAPINE (View Mirtazapine Review and Mirtazapine Label ), XANOR (View Xanor Review and Xanor Label ), NEXIUM (View Nexium Review and Nexium Label ), LEVOLAC (View Levolac Review and Levolac Label ), GASTROZEPIN (View Gastrozepin Review and Gastrozepin Label ).

5630906-7 | Akathisia, Tremor, Visual Disturbance
Adverse event was reported on Feb 07, 2008 by a Female patient taking Tresleen (View Usage) (Dosage: Daily Dose:100mg-text:daily) . Location: AUSTRIA , 24 years of age, After Tresleen was administered, patient had the following side effects: akathisia, tremor, visual disturbance. During the same period patient was treated with CLOZAPINE (Daily Dose:475mg-text:daily) (View Clozapine Review and Clozapine Label ), AKINETON (View Akineton Review and Akineton Label ), OXAZEPAM (View Oxazepam Review and Oxazepam Label ), AMITRIPTYLINE HCL (View Amitriptyline Hcl Review and Amitriptyline Hcl Label ).

5625077-7 | Pleurothotonus
on Feb 01, 2008 Female patient from AUSTRIA , 71 years of age, was diagnosed with dementia alzheimer's type and was treated with Tresleen (View Usage). Patient experienced the following unwanted or unexpected effects: pleurothotonus. Tresleen dosage: . During the same period patient was treated with HALDOL (Daily Dose:1.5mg) (View Haldol Review and Haldol Label ), ARICEPT (View Aricept Review and Aricept Label ), SEROQUEL (Daily Dose:200meq) (View Seroquel Review and Seroquel Label ), MIRTAZAPINE (View Mirtazapine Review and Mirtazapine Label ), XANOR (View Xanor Review and Xanor Label ), NEXIUM (View Nexium Review and Nexium Label ), LEVOLAC (View Levolac Review and Levolac Label ), GASTROZEPIN (View Gastrozepin Review and Gastrozepin Label ).


5440998-6 | International Normalised Ratio Decreased
on Aug 22, 2007 Male patient from AUSTRIA , 45 years of age, was treated with Tresleen (View Usage). Patient had the following side effects: international normalised ratio decreased. Tresleen dosage: . During the same period patient was treated with IVADAL (Daily Dose:20mg) (View Ivadal Review and Ivadal Label ), MARCUMAR (Text:3-4.5mg) (View Marcumar Review and Marcumar Label ), SIMVASTATIN (Daily Dose:20mg) (View Simvastatin Review and Simvastatin Label ), INSULATARD (View Insulatard Review and Insulatard Label ). Patient was hospitalized.

5411494-7 | International Normalised Ratio Increased, Prothrombin Time Shortened
Patient was taking Tresleen (View Usage). After Tresleen was administered, patient had the following side effects: international normalised ratio increased, prothrombin time shortened on Jul 31, 2007 from AUSTRIA Additional patient health information: Male patient , 45 years of age, . Tresleen dosage: . During the same period patient was treated with IVADAL (Daily Dose:20mg) (View Ivadal Review and Ivadal Label ), MARCUMAR (Text:3-4.5mg) (View Marcumar Review and Marcumar Label ), SIMVASTATIN (Daily Dose:20mg) (View Simvastatin Review and Simvastatin Label ), INSULATARD (View Insulatard Review and Insulatard Label ). Patient was hospitalized.

5399767-8 | Mental Disorder, Psychomotor Hyperactivity
Adverse event was reported on Jul 18, 2007 by a Male patient taking Tresleen (View Usage) (Dosage: ) . Location: AUSTRIA , 18 years of age, Patient experienced the following unwanted or unexpected effects: mental disorder, psychomotor hyperactivity.

5320720-4 | Blood Immunoglobulin E Increased
on May 03, 2007 Male patient from AUSTRIA , child 10 years of age, was treated with Tresleen (View Usage). Patient had the following side effects: blood immunoglobulin e increased. Tresleen dosage: .

5225498-0 | International Normalised Ratio Decreased
on Jan 24, 2007 Male patient from AUSTRIA , 45 years of age, was treated with Tresleen (View Usage). After Tresleen was administered, patient had the following side effects: international normalised ratio decreased. Tresleen dosage: . During the same period patient was treated with IVADAL (Daily Dose:20mg) (View Ivadal Review and Ivadal Label ), MARCUMAR (Text:3-4.5mg) (View Marcumar Review and Marcumar Label ), SIMVASTATIN (Daily Dose:20mg) (View Simvastatin Review and Simvastatin Label ), INSULATARD NPH HUMAN (View Insulatard Nph Human Review and Insulatard Nph Human Label ). Patient was hospitalized.

5218205-9 | International Normalised Ratio Decreased
Patient was taking Tresleen (View Usage). Patient experienced the following unwanted or unexpected effects: international normalised ratio decreased on Jan 15, 2007 from AUSTRIA Additional patient health information: Male patient , 45 years of age, . Tresleen dosage: . During the same period patient was treated with IVADAL (Daily Dose:20mg) (View Ivadal Review and Ivadal Label ), SIMVASTATIN (Daily Dose:20mg) (View Simvastatin Review and Simvastatin Label ), MARCUMAR (View Marcumar Review and Marcumar Label ), INSULATARD NPH HUMAN (View Insulatard Nph Human Review and Insulatard Nph Human Label ). Patient was hospitalized.